Company intelligence / Profile preview

Azure Capital

China

Ownership: Private
Development stage: Other

Overview

Azure Biotech is commercial, distributing over 100 rapid diagnostic, IVD, and analyzer products. Their drug detection reagents have leading market share in parts of Europe and are widely distributed globally

Therapeutic areas: CardiovascularImmunologyWomen's HealthInfectious DiseasesPsychiatryOncology
Modalities: Monoclonal antibodySmall moleculeAntisense oligonucleotideDiagnostic reagentRecombinant proteinGenetic engineering platform
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborations with leading research institutions globally

Beyond the preview

Go deeper on Azure Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azure Capital.

Explore the full profile